Navigation Links
UNC expert: Better decision support tools needed for prostate cancer screening choice
Date:9/28/2009

CHAPEL HILL - Although screening for prostate cancer with the Prostate Specific Antigen (PSA) test in men ages 50-70 can detect the cancer before it becomes symptomatic, knowing whether screening is beneficial for these men is uncertain.

Recent trials have shown small or no reductions in prostate cancer mortality among those screened. The small potential for benefit must be balanced against the more common and immediate downsides of increasing the chance of prostate cancer diagnosis and treatment-related complications.

Developing more effective decision support tools may help men and their physicians discuss whether or not to undertake PSA screening.

Michael Pignone, M.D., M.P.H., authored an editorial in the Sept. 28 Archives of Internal Medicine about this issue. He reviewed two studies: one from the National Survey of Medical Decisions and a second study from Australia that modeled the potential effects of screening for use in discussions about screening.

Pignone is associate professor of medicine and chief of the division of general internal medicine in the UNC School of Medicine and a member of UNC Lineberger Comprehensive Cancer Center.

He explained, "To make a good decision about whether or not to be screened, patients need to know their chances of being helped by screening and their chances of being harmed."

"The National Survey of Medical Decisions suggests that patients are not being regularly informed about the advantages and disadvantages of screening. The downsides of screening were talked about in only 32 percent of the discussions. Half of the patients couldn't answer any of the knowledge questions correctly about screening risks.

The Australian study provides updated data for such conversations: screening increases the chance of being diagnosed with prostate cancer from 23 per 1000 to 53 per 1000 over 10 years. The number of men with treatment related impotence or incontinence would also be twice as common: about 26 per 1000 vs. 12 per 1000. The chance of death from prostate cancer would be reduced from 4 in 1000 to 3 in 1000."

"The next step is to study whether providing patients with such information and determining if it changes their knowledge and preferences about screening."


'/>"/>

Contact: Dianne Shaw
dgs@med.unc.edu
919-966-5905
University of North Carolina School of Medicine
Source:Eurekalert  

Related medicine news :

1. Expert: Long-term care health coverage a hidden casualty of economic slide
2. Food Safety Expert: Americans Not Aware of Ongoing Risk & Complications of Salmonella Poisoning
3. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
4. Waist-to-hip ratio may better predict cardiovascular risk than body mass index
5. Informational handout key to giving parents a better understanding of CT radiation risks
6. Children of depressed moms do better when dad is involved, SLU researcher finds
7. Struggling male readers respond better to female teachers
8. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
9. Mothers Know Best: NFL Moms Team With Eddie George to Showcase a Better Way to a Healthier Lifestyle
10. Researchers Find Better Way to Deliver Blood Thinner
11. Clinical trials present better alternatives for dialysis patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UNC expert: Better decision support tools needed for prostate cancer screening choice
(Date:3/28/2017)... ... 28, 2017 , ... METTLER TOLEDO Process Analytics is launching ... water and steam. , Chlorides and sulfates cause pitting and stress corrosion in ... and unplanned shutdowns. Monitoring these ions at low ppb levels has therefore been ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Columbus OH. Dr. ... as one of few medical professionals in the country to sit on the 2017 ... Juvly Aesthetics, in just 2 years Dr. Harper helped propel the clinic from a ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... of SkyLex Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon ... and this procedure adds to SkyLex Advanced Surgical’s already comprehensive list of ...
(Date:3/28/2017)... ... March 28, 2017 , ... With expansion and efficiency in mind, Patten ... , The seed processing plant opened in Marshallville in 2006, and a bagging and ... allows opportunity for transition of Patten Seed operations to the Middle Georgia location from ...
(Date:3/28/2017)... ... ... Thank you to all who attended Capio Partners Winter 2017 Healthcare Leadership Symposium in ... and offered an opportunity to collaborate and network with healthcare colleagues across the United ... gathered for a lively discussion on trends and issues that healthcare leaders will face ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017 The National University of ... data analytics company, signed a Memorandum of Understanding ... delivery in the region. Under ... Research and Technology (BIGHEART) at NUS and Holmusk ... related to healthcare IT and medical device development. ...
(Date:3/27/2017)... , March 27, 2017 ... specialty clinical-stage pharmaceutical company specializing in the development of ... public offering in the United States ... each ADS representing 40 ordinary shares of the ... In addition, Therapix has granted the underwriters a ...
(Date:3/27/2017)... Calif. , March 27, 2017  Cryoport, Inc. ... that it intends to offer shares of common stock ... registration statement on file with the Securities and Exchange ... and other conditions, and there can be no assurance ... completed, or as to the actual size or terms ...
Breaking Medicine Technology: